So far, only a small number of plaintiffs' lawyers have been able to go toe to toe with Merck & Co. in court over its drug Vioxx.

At first, John McDarby's case looked like a loser. Frail, elderly and confined to a wheelchair after two broken hips, he was a 77-year-old diabetic with clogged arteries.

Nearly 40 Alabama residents have filed suit against a Florida-based mortgage service provider, claiming the company improperly charged home owners in a variety of ways.

Multiple trials are set in several Alabama counties this year, beginning in April, against Ocwen Loan Servicing LLC, formerly Ocwen Federal Bank FSB. Ocwen, headquartered in West Palm Beach, Florida, is the largest third-party mortgage service provider in the United States.

Barbour County could be back in the national tort spotlight this summer when plaintiff lawyer Jere Beasley and his firm take pharmaceutical giant Pfizer to court over its arthritis drug Celebrex.

Merck tried its best to hide the fatal risks of taking Vioxx and aggressively marketed the drug to drown out any questions about safety.

A judge set a June 6 trial date for a lawsuit filed by a woman who claims the arthritis medication Celebrex was to blame for a stroke she suffered last year.

The New York drug giant says worldwide annual Celebrex sales this year should surpass $2 billion, a growth trend in sharp contrast to the huge loss in sales that the prescription for pain relief from arthritis experienced last year.

A Celebrex lawsuit has been set for trial in the Circuit Court of Barbour County on June 6, 2006, for a woman who suffered a stroke at age 53, allegedly caused by taking the pain relieving drug, Celebrex.

A Celebrex lawsuit has been set for trial on June 6, 2006 for a woman who suffered a stroke at age 53, caused by taking the pain relieving drug, Celebrex. The trial will take place in the Circuit Court of Barbour County in Alabama. It will most likely be the first Celebrex case to be tried in the country.